| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44367c7b17bf07d2d403f117a3fe1a97 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate |
2005-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c28f47e7e0b6f69fef3b1a1f246ed7df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a525305c7980ce861578dd1ec79f1b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_624ad1b05bcf7b0c95edccea19a75b34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a734dc126251ed30d8c31c77871138df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3187024e5f5dfba7d311b4a295b274a1 |
| publicationDate |
2007-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1741712-A2 |
| titleOfInvention |
Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of Nebivolol |
| abstract |
The present invention provides an improved process for the synthesis of nebivolol or its pharmaceutically acceptable salts, more particularly hydrochloride salt of formula (I). The present invention further provides a new Form T1 of nebivolol and its pharmaceutically acceptable salts. The present invention also provides pharmaceutical compositions and process for the preparation of a solid oral dosage form of nebivolol hydrochloride of formula (I), without the use of wetting agent, and optionally using binder and /or disintegrant. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120129952-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8487122-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011098474-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785664-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011149206-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011149206-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011214396-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-019691-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-RM20100053-A1 |
| priorityDate |
2004-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |